Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573508 · ClinicalTrials.gov registry record · Phase 4
Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life
A Phase 4 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 768
- Enrollment target
NCT00573508 is a Phase 4 study that has completed, run by Astellas Pharma. The registered enrollment target is 768 participants.
The verdict
NCT00573508, a Phase 4 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 768 participants
- Enrollment target
Study Summary
Evaluate the effect of VESIcare® on symptom bother for subjects with OAB
Interventions
- DRUG Placebo
- DRUG Solifenacin Succinate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 768 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00573508
The ClinicalTrials.gov registry entry for NCT00573508 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 768 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00573508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00573508 about?
NCT00573508 is a clinical study titled "Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life". Evaluate the effect of VESIcare® on symptom bother for subjects with OAB
What is the current status of trial NCT00573508?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 768 participants. The study started on 2007-08. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00573508?
The interventions under investigation include: Placebo (DRUG), Solifenacin Succinate (DRUG).
Who is sponsoring clinical trial NCT00573508?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.